to compare the vertical soft tissue gain following augmentation using subepithelial connective tissue graft vs volume stable collagen matrix with simultaneous dental implant placement

Evaluation of the crestal soft tissue thickness and crestal bone level changes following vertical soft tissue augmentation with dental implant using subepithelial connective tissue graft and volume stable collagen matrix a randomized clinical study - nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/02/081314

Enrollment

Registered

2025-02-25

Start date

Unknown

Completion date

Unknown

Last updated

2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K068- Other specified disorders of gingiva and edentulous alveolar ridge Health Condition 2: K068- Other specified disorders of gingiva and edentulous alveolar ridge

Interventions

Intervention1: Augmentation of vertical soft tissue thickness simultaneous with dental implant placement: To evaluate and compare the efficacy of autogenous subepithelial connective tissue graft to vo

Eligibility

Inclusion criteria

Inclusion criteria: 1)systemically healthy patients aged from 20 years to 50 years 2)Localised edentulous site with adjacent healthy teeth to be present 3)Patients with thin crestal mucosal thickness i.e. less than 3mm covering edentulous alveolar ridge 4)Minimum 6mm of edentulous osseous ridge dimension so no hard tissue augmentation is required 5)Patient willing to paticipate in the study ready to give written consent and regular follow up

Exclusion criteria

Exclusion criteria: 1)No bone augmentation procedures before and during implant placement. 2)Any complications during implant placement which require advanced bone regenerative procedures. 3)Patients with history of any allergy. 4)Systemic diseases such as diabetes mellitus, hypertension or conditions that alters the outcome of periodontal therapy (e.g. HIV, Hepatitis). 5)Patient showing active infection in mouth. 6)Pregnant and lactating women. 7)Psychiatric illness.

Design outcomes

Primary

Measure	Time frame
To evaluate the crestal soft tissue thickness following vertical soft tissue augmentation with dental implant using subepithelial connective tissue graft and volume stable collagen matrixTimepoint: 1)VT0 at baseline 2)VT1 after 4 months	—

Secondary

Measure	Time frame
To evaluate the crestal bone level changes following vertical soft tissue augmentation with dental implant using subepithelial connective tissue graft & volume stable collagen matrixTimepoint: 1)T0 at baseline 2)after 4 months	—

Countries

India

Contacts

Public ContactDr Neha Patle

Government College of Dentistry Indore

smadhu16feb@yahoo.co.in9406928976

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026